share_log

Denali Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Capital Research Global Investors(5.5%)

SEC ·  Nov 12, 2024 10:58
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more